ABOUT   |   AIMS and SCOPE   |   AUTHOR INSTRUCTIONS   |   EDITORIAL BOARD   |   ARCHIVE   |   CURRENT ISSUE   |   SUBMIT MANUSCRIPT ONLINE  |

This Article

Copyright © 2012 | AIZEON publishers | All rights reserved

 Open Access
 Abstract Free
 Full Text PDF Free

 

Services

Articles by corresponding author in PubMed

Articles by corresponding author in Google Scholar

 

 

 

aizeon

 



 

ABSTRACT   REFERENCES  
Journal of Bioinformatics and Research 1(1) 2012: 21-26

Structural Studies on Docking Selective COX-2 Inhibitors


KPS Adinarayana1*, P Ashoka Reddy2, P. Ajay Babu2

1Department of Anatomy, Andhra Medical College, Visakhapatnam – 530001, India.
2Bio-Lab, Research Gateway for Biosciences, 47-3-30, Dwaraka Nagar, Visakhapatnam – 530016, India.

* To whom correspondence should be addressed. Email: kpsanarayana@rediffmail.com

REFERENCES

  1. Vane JR, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature - New Biology. 1971;231:232–235
  2. O"Banion MK, Sadowski HB, Winn V & Young DA, A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Bio Chem 1991;266:23261–23267
  3. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997;24 suppl 49:5-9
  4. Needleman P, Isakson P. The discovery and function of COX-2. J Rheumatol 1997; 24 suppl 49:6-8
  5. Picot D, Loll PI, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994;367:243-249
  6. Roth GI, Stanford N, Majerus PW. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA. 1975;72:3073-3076
  7. Marvin MG. Celecoxib, a selective cyclooxygebase-2 inhibitor for the treatment of Rheumatoid Arthritis and Osteoarthritis. Clinical Therapeutics. 1999;21(9):1497-1513
  8. Teruhiko Shimokawa, Richard J. Kulmacz, David L. Dewitt, and William L. Smith Tyrosine 385 of Prostaglandin Endoperoxide Synthase Is Required for Cyclooxygenase Catalysis J. Bio. Chem. 1990;265(33):20073-20076
  9. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. [published erratum appears in Proc Natl Acad Sci U S A 1999;96:5890] Proc Natl Acad Sci USA 1999;96:272-7
  10. Horatio B. Fung, Harold L. Kirschenbaum, Selective Cyclooxygenase-2 Inhibitors for the Treatment of Arthritis. Clinical Therapeutics 1997;21(7):1131-1157
  11. J.B. Tuynman, M.P. Peppelenbosch and D.J. Richel. COX-2 inhibition as a tool to treat and prevent colorectal cancer. Critical Reviews in Oncology/Hematology 2004;52(2):81-101
  12. 1CX2: 3-dimensional structure downloaded from http://www.rcsb.org/pdb
  13. Jin Li, Kristin M. Lundy DeMello, Henry Cheng, Subas M. Sakya, Brian S. Bronk, Robert J. Rafka, et al. Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-di.uoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine Bioorg. Med. Chem. Lett. 2004;(14):95-98
  14. ISIS Draw, a 2-dimensional chemical molecule drawing software: http://www.mdli.com/
  15. Wang, R.; Lai, L.; Wang, S. Further Development and Validation of Empirical Scoring Functions for Structure-Based Binding Affinity Prediction. J. Comp. Aided Mol. Des. 2002;16:11-26
  16. CAChe Work System Pro Version 6.1.1, http://www.cachesoftware.com/
  17. Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy, Paul J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997;23(1-3):3-25
  18. Lipinski’s rule of 5 evaluated from http://www.logp.com
  19. Muegge, I., and Martin, Y., A General and Fast Scoring Function for Protein-Ligand Interactions: A Simplified Potential Approach. J. Med. Chem. 1999;42:791-804
  20. Muegge, I., The Effect of Small changes in Protein Structure on Predicted Binding Modes of Known Inhibitors of Influenza Virus Neuraminidase: PMF-scoring in Dock4. Med. Chem. Res. 1999;(9):490-500
  21. Cornell, W.D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, Jr., K.M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W., and Kollman, P.A. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am. Chem. Soc. 1995;117:5179-5197.


Copyright © 2012 | AIZEON publishers | All rights reserved

..........................................................................................................................................................................................................

Citation: Adinarayana KPS, Reddy PA, Babu PA (2012). Structural Studies on Docking Selective COX-2 Inhibitors. Journal of Bioinformatics and Research 1(1): 21-26

..........................................................................................................................................................................................................

 



 


Template by JustDreamweaver.com